13.40SEK0.00%Mkt Cap: 36.05M $P/E: —Today
Mentice AB (publ), together with its subsidiaries, develops, sells, and markets solutions for training and decision support in the clinical area of interventional angiography in cardiology, neurology, vascular surgery, a…
Industry Peers
Medical Devices$198.81BUSDP/E 36.9
$120.66BUSDP/E 34.7
$125.70BUSDP/E 33.9
$111.66BUSDP/E 24.9
$75.37BUSDP/E 21.1
$53.13BUSDP/E 54.9
$48.43BUSDP/E 19.9
$33.94BUSDP/E 17.2
$33.92BUSDP/E 35.5
$25.08BUSDP/E 20.7
$19.21BUSDP/E 24.5
$16.48BUSDP/E 26.9
$12.87BUSDP/E 80.5
$11.86BUSDP/E 22.6
$11.18BUSD
$10.01BUSDP/E 17.1
$10.51BUSDP/E 28.4
$9.73BUSDP/E 19.8
$9.75BUSDP/E 44.3
$8.82BUSDP/E 25.0
| Headline | Source | Time |
|---|---|---|
Older | ||
Mentice AB (FRA:MN2) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ... Mentice AB (FRA:MN2) reports a 28% revenue increase and significant order intake growth, driven by strategic initiatives and partnerships. | ||
Mentice AB (FRA:MN2) Q4 2025 Earnings Call Highlights: Strong Organic Growth and Improved Margins Mentice AB (FRA:MN2) reports robust Q4 performance with significant organic growth and enhanced EBITDA margins, despite challenges in operational cash flow and regional sales. | ||
Mentice AB (FRA:MN2) Q3 2025 Earnings Call Highlights: Strong Sales Growth Amidst Operational ... Mentice AB reports a 22% increase in net sales and strategic cost reductions, while navigating order intake timing issues and regional market challenges. | ||